| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/17/2009 | US20090233317 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 09/17/2009 | US20090233315 Melanoma-associated antigen C2 (MAGE-C2); for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring |
| 09/17/2009 | US20090233311 receptor binding assay; analysis and determining the level of procalcitonin in blood wherein an increased level of procalcitonin compared to healthy individuals is indicative of sepsis |
| 09/17/2009 | US20090233110 Use of polypeptides in the form of adhesive agents |
| 09/17/2009 | US20090232963 Diazonium salt modification of silk polymer |
| 09/17/2009 | US20090232911 Use of sericin for improving feeling in use of denture |
| 09/17/2009 | US20090232909 Method for determining physiological effects of hemoglobin |
| 09/17/2009 | US20090232847 Immunogenic compositions |
| 09/17/2009 | US20090232842 HPV Vaccine Comprising Peptides From Host Cell Proteins |
| 09/17/2009 | US20090232841 Optimzed vaccines to provide protection against ebola and other viruses |
| 09/17/2009 | US20090232839 Glycoprotein-100 peptide for use as tool in treatment and diagnosis of cancer and viral infection |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232825 Methods and Compositions For Modulating Immunity |
| 09/17/2009 | US20090232824 Bivm (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof |
| 09/17/2009 | US20090232822 Lung disease targets and uses thereof |
| 09/17/2009 | US20090232820 Neisseria meningitidis antigens and compositions |
| 09/17/2009 | US20090232816 Il-1 eta dna and polypeptides |
| 09/17/2009 | US20090232815 Monoclonal antibody or antibody fragment which binds a pleiotrophin-binding fragment of human Anaplastic Lymphoma Kinase (ALK) and inhibits a pleiotrophin-mediated activity; prevents pleiotrophin-mediated neoplastic or mitogenic activity |
| 09/17/2009 | US20090232812 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232808 Molecules and chimeric molecules thereof |
| 09/17/2009 | US20090232799 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor |
| 09/17/2009 | US20090232797 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/17/2009 | US20090232771 Method of controlling cell functions |
| 09/17/2009 | US20090229669 Protein-Based Photovoltaics and Methods of Use |
| 09/17/2009 | DE102008014880A1 Use of a polypeptide with the activity of repulsive guidance molecule A as an antiinflammatory agent |
| 09/17/2009 | CA2718495A1 Recombinant production of authentic human proteins using human cell expression systems |
| 09/17/2009 | CA2718237A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | CA2717997A1 Fusion protein with directioning of vaccinal antigens toward antigen-presenting cells and the applications thereof |
| 09/17/2009 | CA2717699A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | CA2717221A1 Reagents and methods for detecting influenza virus proteins |
| 09/16/2009 | EP2101176A1 Diagnosis of and vaccination against Aspergillus fumigatus |
| 09/16/2009 | EP2101175A1 High order nanostructure and sensor and use of same |
| 09/16/2009 | EP2100968A1 Method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
| 09/16/2009 | EP2100960A2 Specific polypeptides and nucleic acids of pathogenic strains of the Neisseria genus |
| 09/16/2009 | EP2100959A2 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/16/2009 | EP2100958A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 09/16/2009 | EP2100955A2 Attenuated mutants of human parainfluenza virus type 1 (HPIV1) |
| 09/16/2009 | EP2100904A1 Solid phase for use in a method for the purification of albumin conjugates |
| 09/16/2009 | EP2100901A1 Modified Insulin and conjugates thereof |
| 09/16/2009 | EP2100620A1 Nucleic acids encoding polyepitope polypeptides |
| 09/16/2009 | EP2100507A1 Substance capable of inhibiting cytokinin signaling |
| 09/16/2009 | EP2099927A2 Methods of reducing porcine circovirus-associated disease outbreaks |
| 09/16/2009 | EP2099920A1 Transgenic mice expressing humanized vegf |
| 09/16/2009 | EP2099913A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 09/16/2009 | EP2099821A2 Novel genes and proteins that home to developing microvessels |
| 09/16/2009 | EP2099820A2 A recombinant meso-active thermo-stable protein and the process of design and biosynthesis thereof |
| 09/16/2009 | EP2099819A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 09/16/2009 | EP2099818A2 Bacillus licheniformis chromosome |
| 09/16/2009 | EP2099817A2 Ob-fold used as scaffold for engineering new specific binders |
| 09/16/2009 | EP2099816A1 Oxocarbonamide peptide nucleic acids and methods of using same |
| 09/16/2009 | EP2099495A2 Conjugates of a g-csf moiety and a polymer |
| 09/16/2009 | EP2099490A1 New drug for inhibiting, preventing or treatment of rheumatoid arthritis |
| 09/16/2009 | EP2099488A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 09/16/2009 | EP2099484A1 Treatment of prdc in pigs |
| 09/16/2009 | EP2099471A2 Uses of cerberus, coco and derivatives thereof |
| 09/16/2009 | EP1994048B1 Pegylated mutated clostridium botulinum toxin |
| 09/16/2009 | EP1871788B1 Axmi-027 a family of delta-endotoxin genes and methods for their use |
| 09/16/2009 | EP1787127B1 Molecular diagnostic method and treatment in dementia with lewy bodies |
| 09/16/2009 | EP1771471B1 Genetically modified human natural killer cell lines |
| 09/16/2009 | EP1704507B1 Methods and system for the identification and charcterization of peptides and their functional relationships by use of measures of correlation |
| 09/16/2009 | EP1699931B1 Maize metallothionein 2 promoter and methods of use |
| 09/16/2009 | EP1642969B1 Fluorescent protein and pigment protein |
| 09/16/2009 | EP1625395B1 Method for identifying tff2 regulating agents |
| 09/16/2009 | EP1542732B1 Fusion proteins of mycobacterium tuberculosis |
| 09/16/2009 | EP1533375B1 Method of transferring mutation into target nucleic acid |
| 09/16/2009 | EP1517919B9 Marked peptides having affinity for a phospholipid and uses |
| 09/16/2009 | EP1414948B1 Inhibition of apoptosis process and improvement of cell performance |
| 09/16/2009 | EP1408050B1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1377608B1 Insulin precursors and a process for their preparation |
| 09/16/2009 | EP1356064B1 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof |
| 09/16/2009 | EP1349568B1 Immunomodulatory constructs and their uses |
| 09/16/2009 | EP1343814B1 Immunogenic glycopeptides, screening, preparation and uses |
| 09/16/2009 | EP1100815B1 Protease susceptibility ii |
| 09/16/2009 | EP1095144B1 Enhancer elements for increased translation in plant plastids |
| 09/16/2009 | EP1093462B1 Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
| 09/16/2009 | EP1083899B1 Derivatives of 1-deoxy-galactonojirimycin and their use in the treatment of lysosomal storage diseases by enhancing lysosomal alpha-galactosidase a |
| 09/16/2009 | EP1002084B1 Mammalian cytokine: interleukin-b30 and related reagents |
| 09/16/2009 | CN101535342A Pharmacological chaperones for treating obesity |
| 09/16/2009 | CN101535341A Human GLP-1 mimetibodies, compositions, methods and uses |
| 09/16/2009 | CN101535340A Erythropoietin compositions |
| 09/16/2009 | CN101535339A Modified proteins |
| 09/16/2009 | CN101535338A Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 09/16/2009 | CN101535333A Process for controlling protein to salt ratio in animal muscle protein composition and protein composition reference to related application |
| 09/16/2009 | CN101533029A Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 09/16/2009 | CN101533024A Application of Yersinia pestis Caf1M protein |
| 09/16/2009 | CN101532060A Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 09/16/2009 | CN101532023A Bt cryaAc22 gene with insecticidal activity for Lepidoptera insect and application thereof |
| 09/16/2009 | CN101532022A Homeobox gene HTF1 capable of regulating conidium germination of Magnaporthe grisea of and use thereof |
| 09/16/2009 | CN101532021A Phenol degrading and regulating gene and acting promoter thereof |
| 09/16/2009 | CN101532019A Core fragment of human ZHX2 transcription factor and application thereof |
| 09/16/2009 | CN101531719A Polypeptide antigen of avian influenza genetic engineering |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531714A Method for extracting protein from waste mycelia obtained by producing itaconic acid by fermentation method |
| 09/16/2009 | CN101531713A Bt protein Cry56Aal as well as encoding gene thereof and application thereof |
| 09/16/2009 | CN101531712A Bt protein Cry30Bal as well as encoding gene thereof and application thereof |
| 09/16/2009 | CN101531711A Bt protein Cry52Bal as well as encoding gene thereof and application thereof |
| 09/16/2009 | CN101531710A rF1 antigen, preparation method and application thereof |
| 09/16/2009 | CN101531709A Method for cutting Yersinia pestis F1 antigen and relative application thereof |